Risk Channel

Risk intelligence to lead, innovate & grow.

Want to get your daily slice of Risk knowledge to your inbox? Sign up now

Risk Channel helps you stay ahead of essential risk news shaping your profession. Every weekday, our unique blend of AI, risk experts and researchers monitor 100,000s of articles to share a summary of the most relevant and useful content to help you lead, innovate and grow.

From supply chain to regulatory enforcement, data privacy, GRC controls, whistleblowers, and risk management strategies. Risk Channel is the only trusted online news source dedicated to covering current headlines, articles, reports and interviews to make sure you’re at the forefront of changes in the risk industry.

HT banner
Recent Editions
rc-recent-na
Risk Channel
North America
Gilead prevails in 'duty to innovate' case

The California Supreme Court has ruled 6-1 in favor of Gilead Sciences in a case which addresses whether ‌manufacturers of drugs that are considered safe must try developing drugs that could be safer. California's ​highest court ordered the dismissal of negligence claims against the Foster City, California-based company by an estimated 24,000 patients using TDF, an HIV drug it produced, over its decision more than 20 ​years ago to stop developing tenofovir alafenamide fumarate, ⁠or TAF, which was similar to TDF but had fewer side effects. "What today’s decision declines to do is ​recognize, for the first time anywhere, sweeping liability for injuries caused by a concededly nondefective ⁠drug because the manufacturer allegedly failed to make a different drug available sooner," Justice Joshua Groban wrote for the majority. "Imposing ​such liability would create substantial burdens and would risk adverse consequences for pharmaceutical innovation, public health, and patient safety."

Full Issue
rc-recent-eu
Risk Channel
UK/Europe
UK regulator relaxes IPO rules

The UK's Financial Conduct Authority (FCA) has introduced immediate reforms to simplify listing rules, as the City watchdog looks to revitalise London's stock market. Key changes include removing the mandatory seven-day waiting period between publication of an approved prospectus and associated investment research, allowing issuers and their advisers to respond more quickly to market conditions. The FCA said the reforms are intended to improve the efficiency and competitiveness of UK capital markets while maintaining investor protections. Jon Relleen, director of infrastructure and exchanges at the FCA, said: "By making the UK listing regime more efficient, we are supporting the growth and competitiveness of UK capital markets." Inigo Esteve, partner at law firm White & Case, said the "sensible, targeted reforms . . . remove unnecessary friction from the UK IPO process," adding that the changes "demonstrate the FCA's continued willingness to refine the regulatory framework where it can improve the efficiency and competitiveness of London's public markets."

Full Issue
top-shadow
Read the latest Risk highlights